📣 VC round data is live. Check it out!

EUDA Health Valuation Multiples

Discover revenue and EBITDA valuation multiples for EUDA Health and similar public comparables like Vanfund Urban Investment, Mach7 Technologies, PharmX Technologies, Mentice and more.

EUDA Health Overview

About EUDA Health

EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.


Founded

2021

HQ

Singapore

Employees

99

Website

euda.com

Financials (FY)

Revenue: $7M
EBITDA: ($2M)

EV

$44M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

EUDA Health Financials

EUDA Health reported last fiscal year revenue of $7M and negative EBITDA of ($2M).

In the same fiscal year, EUDA Health generated $3M in gross profit, ($2M) in EBITDA losses, and had net loss of ($3M).


EUDA Health P&L

In the most recent fiscal year, EUDA Health reported revenue of $7M and EBITDA of ($2M).

EUDA Health is unprofitable as of last fiscal year, with gross margin of 44%, EBITDA margin of (31%), and net margin of (41%).

See analyst estimates for EUDA Health
Last FY202320242025202620272028
Revenue$7M$4M$4M$7M
Gross Profit$3M$842K$762K$3M
Gross Margin44%23%19%44%
EBITDA($2M)($8M)($17M)($2M)
EBITDA Margin(31%)(224%)(434%)(31%)
EBIT Margin(36%)(107%)(64%)(36%)
Net Profit($3M)($10M)($15M)($3M)
Net Margin(41%)(271%)(383%)(41%)
Net Debt$2M

Financial data powered by Morningstar, Inc.

EUDA Health Stock Performance

EUDA Health has current market cap of $42M, and enterprise value of $44M.

Market Cap Evolution


EUDA Health's stock price is $16.94.

EUDA Health share price increased by 16.6% in the last 30 days, and by 364.1% in the last year.

EUDA Health has an EPS (earnings per share) of $-1.11.

See more trading valuation data for EUDA Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$44M$42M10.9%16.6%-13.1%364.1%$-1.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

EUDA Health Valuation Multiples

EUDA Health trades at 6.5x EV/Revenue multiple, and (21.2x) EV/EBITDA.

See NTM and 2027E valuation multiples for EUDA Health

EUDA Health Financial Valuation Multiples

As of May 5, 2026, EUDA Health has market cap of $42M and EV of $44M.

EUDA Health has a P/E ratio of (15.2x).

Last FY202320242025202620272028
EV/Revenue6.5x12.0x11.0x6.5x
EV/EBITDA(21.2x)(5.3x)(2.5x)(21.2x)
EV/EBIT(18.2x)(11.2x)(17.2x)(18.2x)
EV/Gross Profit14.8x52.6x58.1x14.8x
P/E(15.2x)(4.2x)(2.8x)(15.2x)
EV/FCF(17.5x)(15.2x)(20.6x)(17.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified EUDA Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

EUDA Health Margins & Growth Rates

In the most recent fiscal year, EUDA Health reported gross margin of 44%, EBITDA margin of (31%), and net margin of (41%).

See estimated margins and future growth rates for EUDA Health

EUDA Health Margins

Last FY20242025202720282029
Gross Margin44%19%44%
EBITDA Margin(31%)(434%)(31%)
EBIT Margin(36%)(64%)(36%)
Net Margin(41%)(383%)(41%)
FCF Margin(37%)(54%)(37%)

EUDA Health Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth8%70%
Gross Profit Growth(9%)293%
EBITDA Growth110%(88%)
EBIT Growth(35%)(5%)
Net Profit Growth53%(82%)
FCF Growth(26%)18%

Data powered by FactSet, Inc. and Morningstar, Inc.

EUDA Health Operational KPIs

EUDA Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for EUDA Health
Last FY202320242025202620272028
Revenue per Employee$0.1M
Opex per Employee$0.1M
S&M Expenses to Revenue19%14%3%19%
G&A Expenses to Revenue61%115%80%61%
R&D Expenses to Revenue0%0%
Opex to Revenue80%130%83%80%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EUDA Health Competitors

EUDA Health competitors include Vanfund Urban Investment, Mach7 Technologies, PharmX Technologies, Mentice, Doctor Care Anywhere, Maps, Data Horizon, MeVis, Carelabs and Healixa.

Most EUDA Health public comparables operate across Telemedicine & Virtual Care, Healthcare Software, B2B SaaS, Vertical SaaS and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Vanfund Urban Investment1.3x(6.0x)
Mach7 Technologies1.9x1.6x(27.1x)(20.8x)
PharmX Technologies7.2x38.1x
Mentice1.2x1.2x80.4x24.5x
Doctor Care Anywhere0.8x0.7x6.8x7.0x
Maps1.3x1.0x4.7x5.3x
Data Horizon2.2x(3.6x)
MeVis2.2x10.5x

This data is available for Pro users. Sign up to see all EUDA Health competitors and their valuation data.

Start Free Trial

EUDA Health M&A Activity

EUDA Health has acquired 2 companies to date.

Last acquisition by EUDA Health was on August 28th 2025. EUDA Health acquired Chemokine for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by EUDA Health

Chemokine
CK Health Plus
Description
Chemokine is a developer of immune health supplements featuring molecular compounds and gene-modulating formulations. Based in the United States, it produces targeted products that enhance innate immunity through proprietary blends of nucleotides, peptides, and nutraceuticals designed for daily wellness and therapeutic support in viral defense and inflammation management.
HQ CountrySingapore
HQ City
Singapore
Deal Date28 Aug 20256 May 2024
Valuationundisclosed$15M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all EUDA Health acquisitions and their M&A valuation multiples.

Start Free Trial

EUDA Health Investment Activity

EUDA Health has invested in 1 company to date.

Latest investment by EUDA Health was on January 13th 2026. EUDA Health invested in Shenzhen Inno in their Undisclosed stage round.

See VC round multiples

Latest Investments by EUDA Health

Shenzhen Inno
Description
Shenzhen Inno is a Shenzhen-based R&D firm specializing in tumor biomarkers and immunotherapy technologies.
HQ CountryChina
HQ City
Deal Date13 Jan 2026
RoundUndisclosed stage
Raisedundisclosed
InvestorsEUDA Health
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all EUDA Health investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About EUDA Health

When was EUDA Health founded?EUDA Health was founded in 2021.
Where is EUDA Health headquartered?EUDA Health is headquartered in Singapore.
How many employees does EUDA Health have?As of today, EUDA Health has over 99 employees.
Who is the CEO of EUDA Health?EUDA Health's CEO is Alfred Lim.
Is EUDA Health publicly listed?Yes, EUDA Health is a public company listed on Nasdaq.
What is the stock symbol of EUDA Health?EUDA Health trades under EUDA ticker.
When did EUDA Health go public?EUDA Health went public in 2022.
Who are competitors of EUDA Health?EUDA Health main competitors include Vanfund Urban Investment, Mach7 Technologies, PharmX Technologies, Mentice, Doctor Care Anywhere, Maps, Data Horizon, MeVis, Carelabs, Healixa.
What is the current market cap of EUDA Health?EUDA Health's current market cap is $42M.
What is the current revenue of EUDA Health?EUDA Health's last fiscal year revenue is $7M.
What is the current EV/Revenue multiple of EUDA Health?Current revenue multiple of EUDA Health is 6.5x.
Is EUDA Health profitable?No, EUDA Health is not profitable.
How many companies EUDA Health has acquired to date?As of May 2026, EUDA Health has acquired 2 companies.
What was the largest acquisition by EUDA Health?$15M acquisition of CK Health Plus on 6th May 2024 was the largest M&A EUDA Health has done to date.
What companies EUDA Health acquired?EUDA Health acquired CK Health Plus and Chemokine.
In how many companies EUDA Health has invested to date?As of May 2026, EUDA Health has invested in 1 company.
What was the last EUDA Health investment?On 13th January 2026 EUDA Health invested in Shenzhen Inno, participating in a Undisclosed stage round.
In what companies EUDA Health invested in?EUDA Health invested in Shenzhen Inno.

See public comps similar to EUDA Health

Lists including EUDA Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial